Why did you only focus on asthma? Did you check on pneumonia numbers? I also think you're making some dodgy assumptions of RAP's pricing model. I'd imagine it would more be a license charge where its $x amount per diagnosis rather than a flat fee of $20 for the app.
- Forums
- ASX - By Stock
- Ann: Positive Results from Australian Adult Clinical Studies
Why did you only focus on asthma? Did you check on pneumonia...
-
- There are more pages in this discussion • 26 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAP (ASX) to my watchlist
|
|||||
Last
20.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $176.2M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
RAP (ASX) Chart |
Day chart unavailable